<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01323075</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2010/PC-02</org_study_id>
    <secondary_id>2010-024519-15</secondary_id>
    <nct_id>NCT01323075</nct_id>
  </id_info>
  <brief_title>Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes)</brief_title>
  <official_title>Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to demonstrate a longer period of neurologic recovery from a sensory
      block assessed in each test group versus the group without metabolic disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The duration of sensory block in minutes.</measure>
    <time_frame>Day 0 (per-op)</time_frame>
    <description>The duration of the sensory block in minutes. The beginning of this term is defined by the end of the axillary block (last injection), and the end of this period is defined by the reappearance of sensitivity to touch in the area anesthetized.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time necessary for completion of axillary blocks (1 / 3 upper humerus)(min)</measure>
    <time_frame>Day 0 (per-op)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time necessary for installing sensory and motor block (min)</measure>
    <time_frame>Day 0 (per-op)</time_frame>
    <description>Time necessary for installing sensory and motor block (min): defined by the delay between the end of the block injection and the occurrence of insensitivity of blocked territories</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Failure of the block: yes / no</measure>
    <time_frame>Day 0 (per-op)</time_frame>
    <description>Failure of the block: yes / no: defined by an absence of sensory block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of paresthesia: yes / no</measure>
    <time_frame>Day 0 (per-op)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of neurological complications, yes/no</measure>
    <time_frame>Day 0 (post-op)</time_frame>
    <description>Neurological: occurrence of complications (paresthesia, paralysis, paresis ....) that persist (or not) until the final postoperative evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of neurological complications, yes/no</measure>
    <time_frame>1 month</time_frame>
    <description>Occurrence of neurological complications (paresthesia, paralysis, paresis ....)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Renal Insufficiency</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Renal insufficiency group</arm_group_label>
    <description>Patients in this group have renal insufficiency as defined by a creatinine clearance of &lt; 30 ml/min without dialysis. These patients do not have diabetes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetic group</arm_group_label>
    <description>These patients have diabetes, but not renal insufficiency.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-exposed group</arm_group_label>
    <description>These patients have neither a neurological nor a metabolic disease and a creatine clearance of &gt; 90 ml/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Truncal block</intervention_name>
    <description>Patients will have a truncal block during hand or wrist surgery.</description>
    <arm_group_label>Renal insufficiency group</arm_group_label>
    <arm_group_label>Diabetic group</arm_group_label>
    <arm_group_label>Non-exposed group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Three patient populations schelduled for surgery on the hand or wrist. The three groups
        include (1) patients with no metabolic or neurologic disease history, (2) patients with
        renal insufficiency but not diabetes and (3) patients with diabetes but not renal
        insufficiency.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        General Inclusion Criteria:

          -  The patient must have given his/her informed and signed consent

          -  The patient must be insured or beneficiary of a health insurance plan

          -  The patient is available for 1 month of follow up

          -  The patient is scheduled for hand or wrist surgery

        Inclusion Criteria for the &quot;Renal Insufficiency&quot; group

          -  Patient has renal insufficiency as defined by a creatine clearance of &lt; 30ml/min
             without dialysis

        Inclusion Criteria for the &quot;Diabetes&quot; group

          -  Patient has chronic hyperglycemia, either a fasting glycemia &gt; 1.26 g/l (7mmol/l) for
             longer than 5 years and receiving an oral, well-adjusted (last HBA1c &lt; 6.5%)),
             non-insulin, antidiabetic treatment

        Inclusion Criteria for the &quot;Non-exposed&quot; group

          -  Patient without metabolic or neurologic disease, with creating clearance &gt; 90ml/min

        Exclusion Criteria:

          -  The patient is participating in another study

          -  The patient is in an exclusion period determined by a previous study

          -  The patient is under judicial protection, under tutorship or curatorship

          -  The patient refuses to sign the consent

          -  It is impossible to correctly inform the patient

          -  The patient is pregnant

          -  The patient is breastfeeding

          -  Patient weighs less than 50 kg

          -  Score ASA &gt; 4

          -  contra indication for locoregional anesthesia

          -  Severe metabolic and / or decompensated renal disease, cardiac or pulmonary
             decompensation

          -  Associated peripheral neuropathy associated with diabetes or kidney disease

          -  Associated central neuropathy associated (eg MS ... narrow cervical canal)

          -  Patients with both renal failure and diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Cuvillon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nîmes</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <state>Gard</state>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Lapeyronnie CHU de Montpellier</name>
      <address>
        <city>Montpellier Cedex 05</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé Claude Galien</name>
      <address>
        <city>Quincy-sous-Sénart</city>
        <zip>91480</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2011</study_first_submitted>
  <study_first_submitted_qc>March 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2011</study_first_posted>
  <last_update_submitted>March 25, 2015</last_update_submitted>
  <last_update_submitted_qc>March 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

